All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation
During the European School of Haematology (ESH) 5th Translational Research E-Conference on Multiple Myeloma, the Multiple Myeloma Hub spoke to Shaji Kumar, Mayo Clinic, Rochester, US, about the do's and don'ts when diagnosing multiple myeloma.
Do's and don'ts when diagnosing multiple myeloma
Shaji Kumar describes the steps required to diagnose monoclonal gammopathies. The first step is ensuring that there is a monoclonal process in place, and then doing additional investigations to put this in the correct diagnostic group.
Mutated lymphopoiesis and B cell oligoclonality can precede the pathogenesis of multiple myeloma and persist in patients with negative measurable residual disease
At ASH 2019, Sara Rodríguez, Centro de Investigación Médica Aplicada, reported the...
Monthly theme | An introduction to patient reported outcomes (PROs) and quality of life (QoL) assessments in multiple myeloma
This article will introduce PROs and QoL assessments in MM, as well as set the scene for the content that will be following...
Subscribe to get the best content related to multiple myeloma delivered to your inbox